PODD
Insulet Corp. · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -0.7% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | -1 | 427.34K | $55.53M | n/a | −1 |
| Q2 2026 | 160 | 0 | 53.39M | $8.14B | +7 | −6 |
| Q1 2026 | 162 | -3 | 53.76M | $11.28B | +2 | −6 |
| Q4 2025 | 164 | +1 | 61.46M | $17.44B | +2 | n/a |
| Q3 2025 | 24 | +1 | 35.22M | $10.87B | +1 | −1 |
| Q2 2025 | 21 | -2 | 34.19M | $10.74B | n/a | −2 |
| Q1 2025 | 20 | +1 | 10.99M | $2.88B | +1 | n/a |
| Q4 2024 | 19 | 0 | 11.49M | $3.00B | +1 | −1 |
| Q3 2024 | 18 | 0 | 8.60M | $2.00B | +1 | −1 |
| Q2 2024 | 18 | n/a | 10.07M | $2.03B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 2.97M | n/a | $776.57M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Baillie Gifford ✦ | 2.36M | +3.5% | $615.00M | 0.5% | ▲ Add | 3 | SEC ↗ ×4 |
| 3 | Geode Capital Management ✦ (passief) | 1.78M | +2.3% | $463.35M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (passief) | 953.02K | +7.4% | $248.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 729.11K | -26.4% | $190.35M | 0.2% | ▼ Trim | 3 | SEC ↗ ×2 |
| 6 | PRIMECAP Management ✦ | 493.22K | -10.7% | $128.76M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 7 | Marshall Wace ✦ | 486.52K | +29.6% | $127.01M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | Fisher Asset Management ✦ | 377.69K | +7.6% | $98.60M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 325.33K | -3.5% | $84.93M | 0.0% | ▼ Trim | 3 | SEC ↗ ×8 |
| 10 | T. Rowe Price ✦ | 202.73K | +0.4% | $52.93M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 11 | Capital World Investors ✦ | 168.00K | 0.0% | $43.86M | 0.0% | Held | 3 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 158.99K | +45.7% | $41.51M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 158.13K | -8.4% | $41.28M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 14 | Adage Capital Partners ✦ | 155.50K | -39.6% | $40.60M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 100.16K | -18.8% | $26.15M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 16 | Arrowstreet Capital ✦ | 37.62K | Nieuw | $9.82M | 0.0% | New | 1 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 16.98K | -56.6% | $4.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 7.73K | -30.6% | $2.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 6.83K | +57.2% | $1.78M | 0.0% | ▲ Add | 3 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Arrowstreet Capital | $9.82M | 0.0% |
Verlaten
| D. E. Shaw & Co. | $269,525 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 779 houders, 69.27M aandelen, $13.82B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Officer, Director · President and CEO · 1.10K aand @ 147.47 · $162,217
Open-market verkopen (S)
Geen open-market insider-verkopen in ons dekkingsvenster.
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie